32,004 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Merck Acquisitions

Merck has acquired 33 companies and its latest acquisition was Modifi Biosciences, Inc. on Oct 2024

Unlock 30 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Modifi Biosciences, Inc.

Oct 2024

Source »
$30M
Modifi Bio is a Connecticut-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer.
Eyebio Limited

May 2024

Source »
$1.3B
EyeBio is an England-based ophthalmology biotech company that researches and develops novel therapies for the treatment of eye diseases.
Abceutics, Inc.

Apr 2024

Source »
$208M
Abceutics is a New York-based biopharmaceutical company that researches and develops antibody-drug conjugates for the treatment of cancer.
Harpoon Therapeutics, Inc.

Jan 2024

Source »
$680M
Harpoon is a California-based biotechnology company that researches and develops T-cell immunotherapies for the treatment of cancer and infectious diseases.
Caraway Therapeutics, Inc.

Nov 2023

Source »
$610M
Caraway Therapeutics is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of neurodegenerative and rare diseases.

Frequently Asked Questions about Merck

  1. What companies did Merck acquire?

    Companies acquired by Merck include Modifi Bio, EyeBio and Abceutics

  2. How many acquisitions does Merck have?

    Merck has acquired 33 companies including Modifi Bio, EyeBio and Abceutics .

  1. How many acquisitions did Merck make in 2024?

    In 2024 Merck acquired 4 companies including Modifi Bio, EyeBio and Abceutics .